316 related articles for article (PubMed ID: 31786964)
21. Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.
Teschke R
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047633
[TBL] [Abstract][Full Text] [Related]
22. Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison.
Lei X; Zhang J; Xu Q; Li J; Qian Y; Zhang J; Liu L; Zhong W; Wang Y; Han X; Tang J; Zeng M; Mao Y
J Int Med Res; 2021 Aug; 49(8):3000605211039810. PubMed ID: 34433332
[No Abstract] [Full Text] [Related]
23. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.
Teschke R; Danan G
Medicines (Basel); 2020 Sep; 7(10):. PubMed ID: 33003400
[No Abstract] [Full Text] [Related]
24. Significant Medical Comorbidities Are Associated With Lower Causality Scores in Patients Presenting With Suspected Drug-Induced Liver Injury.
Ghabril M; Gu J; Yoder L; Corbito L; Dakhoul L; Ringel A; Beyer CD; Vuppalanchi R; Barnhart H; Hayashi PH; Chalasani N
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00141. PubMed ID: 32251016
[TBL] [Abstract][Full Text] [Related]
25. Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method.
Ye L; Feng Z; Huang L; Guo C; Wu X; He L; Tan W; Wang Y; Wu X; Hu B; Li T; Yang G; Chengxian G; He Q
Front Pharmacol; 2021; 12():790108. PubMed ID: 34987403
[No Abstract] [Full Text] [Related]
26. Causality assessment for suspected DILI during clinical phases of drug development.
Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
[TBL] [Abstract][Full Text] [Related]
27. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.
Teschke R; Eickhoff A; Schulze J; Danan G
Transl Gastroenterol Hepatol; 2021; 6():51. PubMed ID: 34423172
[TBL] [Abstract][Full Text] [Related]
28. Clinical Spectrum and Outcome of Pediatric Drug Induced Liver Injury.
Kumar A; Sood V; Khanna R; Verma SK; Mehra N; Rawat D; Alam S
Indian J Pediatr; 2018 Aug; 85(8):676-678. PubMed ID: 29247427
[TBL] [Abstract][Full Text] [Related]
29. Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic Leukemia as Assessed for Causality Using the Updated RUCAM.
Qin FL; Sang GY; Zou XQ; Cheng DH
Can J Gastroenterol Hepatol; 2022; 2022():5914593. PubMed ID: 35369115
[TBL] [Abstract][Full Text] [Related]
30. The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome.
Naseralallah LM; Aboujabal BA; Geryo NM; Al Boinin A; Al Hattab F; Akbar R; Umer W; Abdul Jabbar L; Danjuma MI
PLoS One; 2022; 17(9):e0268705. PubMed ID: 36048762
[TBL] [Abstract][Full Text] [Related]
31. Highlights of the drug-induced liver injury literature for 2021.
Woo SM; Alhaqqan DM; Gildea DT; Patel PA; Cundra LB; Lewis JH
Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):767-785. PubMed ID: 35839342
[TBL] [Abstract][Full Text] [Related]
32. Drug-Induced Liver Injury: Highlights of the Recent Literature.
Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
[TBL] [Abstract][Full Text] [Related]
33. Reply: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment.
Mullins C; Beaulac K; Sylvia L
Ann Pharmacother; 2021 Jul; 55(7):936. PubMed ID: 33191775
[No Abstract] [Full Text] [Related]
34. Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment.
Danjuma M; Elgara M; Al-Hattab F; Abaro R; Elzouki AN
Ann Pharmacother; 2021 Jul; 55(7):934-935. PubMed ID: 33185108
[No Abstract] [Full Text] [Related]
35. [Clinical and pathological features in 138 cases of drug-induced liver injury].
Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
[TBL] [Abstract][Full Text] [Related]
36. Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM).
Nin Chau T; Cheung WI; Ngan T; Lin J; Lee KW; Tat Poon W; Leung VK; Mak T; Tse ML;
Clin Toxicol (Phila); 2011 Jan; 49(1):34-9. PubMed ID: 21114414
[TBL] [Abstract][Full Text] [Related]
37. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
[TBL] [Abstract][Full Text] [Related]
38. A case report of a drug-induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing.
González-Muñoz M; Monserrat Villatoro J; Marín-Serrano E; Stewart S; Bardón Rivera B; Marín J; Martínez de Soto L; Seco Meseguer E; Ramírez E
Clin Case Rep; 2020 Dec; 8(12):3105-3109. PubMed ID: 33363890
[TBL] [Abstract][Full Text] [Related]
39. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature.
Abeles RD; Foxton M; Khan S; Goldin R; Smith B; Thursz MR; Verma S
BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214235
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China.
Chen Y; Wang C; Yang H; Huang P; Shi J; Tong Y; Jiang J; Zhang X; Chen W; Xuan Z
Biomed Res Int; 2021; 2021():8894498. PubMed ID: 33954202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]